Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 591-600 of 2855 for cancer

Edit search filters
  1. Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed By Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance In Treatment-Naïve Mantle Cell Lymphoma

    Rochester, MN

  2. A Study Of NT-175 In Adult Subjects With Unresectable, Advanced, And/or Metastatic Solid Tumors That Are Positive For HLA-A*02:01 And The TP53 R175H Mutation

    Jacksonville, FL

  3. A Study Evaluating Atezolizumab And Bevacizumab, With Or Without Tiragolumab, In Participants With Untreated Locally Advanced Or Metastatic Hepatocellular Carcinoma (IMbrave152) (SKYSCRAPER-14)

    Jacksonville, FL, Rochester, MN

  4. Positron Emission Tomography Using 64Cu-SAR-bisPSMA In Participants With High-risk Prostate Cancer Prior To Radical Prostatectomy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. (Neo)Adjuvant IDE196 (Darovasertib) In Patients With Localized Ocular Melanoma

    Rochester, MN

  6. A First-in-Human (FIH) Study To Evaluate The Safety And Tolerability Of VVD-159642 In Participants With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ

  7. A Study To Evaluate Testing The Addition Of Targeted Radiation Therapy To Surgery And The Usual Chemotherapy Treatment For Stage I-IIIA Malignant Pleural Mesothelioma

    Rochester, MN

  8. AI-Augmented Imaging For Early Detection Of Pancreatic Cancer Acronym: AI-PACED

    Rochester, MN

  9. Measuring If Immunotherapy Plus Chemotherapy Is Better Than Chemotherapy Alone For Patients With Aggressive Poorly Differentiated Sarcomas

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study To Compare Administering Olaparib Concurrently With Radiotherapy Vs. Radiotherapy Alone In Treating Patients With Inflammatory Breast Cancer

    Eau Claire, WI, La Crosse, WI, Rochester, MN

.

Mayo Clinic Footer